Clinical trial
Effectiveness of Hydroxychloroquine in Covid-19 Patients: A Single Centred Single-blind RCT Study
NCT04328272 is registered in ClinicalTrials.gov with Prof. Dr. Umar Farooq as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Hydroxychloroquine in Covid-19 Patients: A Single Centred Single-blind RCT Study
- Lead sponsor
- Prof. Dr. Umar Farooq
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 28, 2020
- Completion date
- June 28, 2020
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19